For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
15
views
0
references
 Top references
cited by
10
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Outcomes after carotid artery stenting in Medicare beneficiaries, 2005 to 2009.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite increased carotid artery stenting (CAS) dissemination following the 2005 National Coverage Determination, to our knowledge, periprocedural and long-term outcomes have not been described among Medicare beneficiaries.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): JAMA Neurol
          Title: JAMA neurology
          ISSN (Electronic): 2168-6157
          ISSN (Print): 2168-6149
          Publication date (Electronic): Mar 2015
          Volume: 72
          Issue: 3
          Affiliations
          [1 ] Division of Pharmacoepidemiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2LASER ANALYTICA, New York, New York.
          [2 ] Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
          [3 ] Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
          [4 ] Division of Cardiovascular Medicine, Massachusetts General Hospital, Boston.
          [5 ] Ochsner Clinical School, Ochsner Medical Center, New Orleans, Louisiana.
          [6 ] Division of Pharmacoepidemiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
          [7 ] Division of Pharmacoepidemiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts7OptumInsight Epidemiology, Waltham, Massachusetts.
          [8 ] Division of Cardiology, Denver Veterans Affairs Medical Center, University of Colorado, Denver.
          [9 ] Division of Cardiovascular Medicine, St Joseph Mercy Ann Arbor, Ann Arbor, Michigan.
          [10 ] Global Health Outcomes, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
          [11 ] Department of Neurology, Mayo Clinic, Jacksonville, Florida.
          [12 ] Division of Pharmacoepidemiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts12Department of Medicine, Duke Clinical Research Institute, Durham, North Carolina.
          Article
          Publisher Item ID: 2089218
          DOI: 10.1001/jamaneurol.2014.3638
          PubMed ID: 25580726
          SO-VID: 068c7884-c457-436e-add5-67798e3d38b3
          History

          Data availability:

          Comments

          Comment on this article